NattoPharma Awarded 2008 Frost & Sullivan Award

LYSAKER, Norway—NattoPharma's MenaQ7™, a natural vitamin K2 product, received the 2008 Frost & Sullivan Product Innovation of the Year Award in the North American vitamin market; the award is presented each year to a company that has demonstrated excellence in new products and technologies within its industry. According to Frost & Sullivan, "The award is in recognition of the company's unique capability to develop natural vitamin K2 as MenaQ7™ with established and proven bone and heart health benefits. Owing to its natural form coupled with superb bioavailability, MenaQ7 obtained excellent market acceptance."
"We are honored to receive this award from Frost & Sullivan, recognized as a global market analysis and solution leader," commented NattoPharma CEO Egil Greve. "Vitamin K2 has been consumed in Japan for centuries through the food dish natto, however the beneficial health effects have only recently become known in the western world. A major challenge is to educate physicians as well as the public about these health benefits, and NattoPharma has committed itself to do this in a scientific manner."
Greve continued, "We are investing heavily in research & development and we base all our marketing on the solid scientific documentation of our safe and highly effective natural vitamin K2 product, MenaQ7™. We find it very encouraging that this investment, accompanied with NattoPharma's and our U.S. distributor PL Thomas' intense marketing to educate the market about this unique ingredient, has been honored with the award."
Paul Flowerman, president of PL Thomas added: "We are most pleased to have MenaQ7 recognized as an innovative ingredient. It is truly fulfilling to be able to provide a natural product with real health benefits at all stages of one's life. MenaQ7 provides an essential vitamin for neonatal care, for healthy growing and mature bones, and to ensure proper utilization of calcium for cardiovascular health as we age."